Salvato in:
Dettagli Bibliografici
Autore principale: Liliana Torcoroma-García
Natura: Artículo científico
Lingua:en
Pubblicazione: Instituto Nacional de Salud 2021
Soggetti:
Accesso online:https://www.redalyc.org/articulo.oa?id=84368105006
https://www.redalyc.org/journal/843/84368105006/
https://www.redalyc.org/journal/843/84368105006/html/
https://www.redalyc.org/journal/843/84368105006/84368105006.epub
https://www.redalyc.org/journal/843/84368105006/movil
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
Sommario:
  • Disagreement between PCR and serological diagnosis of Trypanosoma cruzi infection in blood donors from a Colombian endemic region Liliana Torcoroma-García Jhancy Rocío Aguilar Marly Yojhana Bueno Erika Marcela Moreno Herminia Ramírez Nelson Daza Medicina serology blood donors Chagas disease Trypanosoma cruzi polymerase chain reaction Introduction: Chagas' disease is the leading cause of infectious myocarditis worldwide. This infection caused by Trypanosoma cruzi is usually life-long and asymptomatic; however, the third part of infected people can develop severe or even fatal cardiomyopathy. As the parasitemia in the chronic phase is both low-grade and intermittent, T. cruzi infection is principally detected by serology, although this method has sensitivity and specificity limitations. Objective: To determine the level of agreement between serologic and molecular tests in 658 voluntary blood donors from six provinces in the Colombian department of Santander. Materials and methods: We evaluated an array of diagnostic technologies by cross-section sampling performing a serological double diagnostic test for T. cruzi antibody detection (Chagas III ELISA™, BiosChile Group, and ARCHITECT Chagas CMIA™, Abbott;, and DNA detection by polymerase chain reaction (PCR). We collected the demographic, clinical, and epidemiological information of participants. The sample size was calculated using Epidat™ and the statistical analysis was done with Stata 12.1™.Results: PCR was six times more sensitive in detecting T. cruzi infection than ELISA/CMIA with prevalence values of 1.8% (12/658) and 0.3% (2/658), respectively, and kappa=0.28 (95%CI: -0.03 - 0.59). In contrast, serology showed a sensitivity of 16.7% (95%CI: 2.09 -48.4) and a specificity of 100% (95%CI: 99.4 - 100). All seropositive samples were found to be positive by PCR.Conclusions: The implementation of PCR as a complementary method for screening donors could reduce the probability of false negative and the consequent risk of transfusional-transmission of Chagas' disease, especially in endemic regions. 2021 artículo científico 0120-4157 https://www.redalyc.org/articulo.oa?id=84368105006 https://www.redalyc.org/journal/843/84368105006/ https://www.redalyc.org/journal/843/84368105006/html/ https://www.redalyc.org/journal/843/84368105006/84368105006.epub https://www.redalyc.org/journal/843/84368105006/movil 10.7705/biomedica.5441 en http://www.redalyc.org/revista.oa?id=843 Biomédica application/pdf Instituto Nacional de Salud Biomédica (Colombia) Num.1 Vol.41